Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden
| Status: | Completed |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/28/2016 |
| Start Date: | June 2010 |
| End Date: | May 2014 |
Assessments (survey data) in this study are designed to sample the symptom burden of
patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no
change in the treatment plan for these patients.
patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no
change in the treatment plan for these patients.
Inclusion Criteria:
- Patients who are receiving doxorubicin plus ifosfamide (AI)
Exclusion Criteria:
- There is no exclusion criteria
We found this trial at
1
site
Click here to add this to my saved trials
